Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the first quarter of 2026 after market ...
A study, conducted by GB Pant Hospital, found that 80% of patients who suffered a first heart attack were not identified as ...
In a field that prides itself on evidence-based medicine, we have allowed a remarkable degree of variation under the banner ...
The Northwestern Medicine Grayslake Outpatient Center continues to evolve as one of Lake County’s most comprehensive ...
A simpler alternative to open heart surgery is gaining popularity, but some find their new valves don’t last as long as they ...
Emerging evidence may help reshape antiplatelet and lipid strategies for the management of coronary artery disease.
PCI for coronary chronic total occlusion significantly improves angina symptom scores compared with placebo in patients with stable angina.
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the US have been successfully treated ...
Stereotaxis (NYSE:STXS) today announced the first patients successfully treated in the U.S. with its MAGiC system.
Results from a new analysis show that patients with mitral annular calcification (MAC) who undergo minimally invasive mitral ...
Clinical experience with Terumo’s Roadsaver™ carotid artery stent system. Edvard Skripochnik, MD Chief, Vascular and ...
Findings from the AltaValve™ Early Feasibility Study suggest that patients with a leaky mitral valve have sustained clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results